Atlas Trials

A Single-dose Study to Investigate the Effect of Injection Site on KAI-9531 Relative Bioavailability in a Range of Body Mass Indices

Clinical trial NCT07044401 · COMPLETED

Trial details

NCT number
NCT07044401
Sponsor
Kailera
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Volunteers
Start date
2025-07-14
Primary completion
2025-11-13
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.